Akta pure 150 m (29046694), akta crossflow (29409303), akta oligopilot 100 (18113679), and accessories for all three systems.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N95021C00018
- Awardee
-
Global Life Sciences Solutions USA LLC UEI FG41DG32EGC3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $460,359
Award facts
- Opportunity
-
- DNA/RNA purification system, filtration system, and synthesizer for NCATS (COVID-19) Pre-Solicitation · 75N95021Q00327 · Posted Jul 15, 2021
- DNA/RNA purification system, filtration system, and synthesizer for NCATS (COVID-19) Award Notice · Posted Aug 20, 2021
- DNA/RNA purification system, filtration system, and synthesizer for NCATS (COVID-19) Solicitation · Posted Jul 23, 2021
- Contract value 100% obligated
- $460,359.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6630 Chemical Analysis Instruments
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Marlborough, MA 01752, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $460,359 |
About this award
This definitive contract awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Global Life Sciences Solutions USA LLC is valued at $460,359.18 to provide three laboratory systems in support of COVID-19 research. The solicitation requested quotations for a Cytiva AKTA pure 150 M or equivalent purification system, a Cytiva AKTA Oligopilot 100 or equivalent synthesis system, and a Cytiva AKTAcrossflow or equivalent ultrafiltration system, to be delivered within 60 days to the NIH campus in Rockville, Maryland. There was no set-aside restriction for this procurement using simplified acquisition procedures for commercial items under the associated North American Industry Classification System code for analytical laboratory instrument manufacturing. The contract period of performance spans from August 19, 2021 to January 6, 2022 at firm fixed prices.
Quick answers
Who was awarded contract 75N95021C00018?
75N95021C00018 was awarded to Global Life Sciences Solutions USA LLC by National Institute on Drug Abuse (National Institutes of Health) on August 19, 2021.
How much is contract 75N95021C00018 worth?
The government has obligated $460,359 on 75N95021C00018.
Which agency awarded contract 75N95021C00018?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021C00018, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95021C00018 competed?
The extent of competition for 75N95021C00018 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award